21476 ⎘
Preparations for testing Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
Sub-classes:DRUG DELIVERY AGENTS FOR PREVENTION OR TREATMENT OF PULMONARY DISEASE
#2System and Methods for Organ-Targeted Multinuclear Functional and Molecular Magnetic Resonance Imaging
#3MRI COMPOSITION AND ITS USE IN NONFASTING SUBJECTS
#4Silk-Hyaluronic Acid Compositions For Tissue Filling, Tissue Spacing, and Tissue Bulking
#5FLUORINE-CONTAINING COMPOUND AND CONTRAST AGENT
#6PURIFIED SIGNAL-ENHANCED CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING
#7SYSTEMS AND METHODS FOR GENERATION OF HYPERPOLARIZED MATERIALS
#8NITROGEN-CONTAINING MACROCYCLIC CONJUGATES AS RADIOPHARMACEUTICALS
#9CONTRAST AGENT FOR DETECTING CARTILAGE DAMAGE AND METHOD AND PROGRAM FOR EXAMINING CARTILAGE DAMAGE USING SAID CONTRAST AGENT
#10Compositions and devices to administer pharmaceutical compositions nasally
#11METHODS AND COMPOUNDS FOR DETECTION AND BINDING OF ALDEHYDES
#12COMPOSITIONS AND METHODS INVOLVING AMINO ACIDS FOR THE TREATMENT OF FAT INFILTRATIONS IN MUSCLE
#13DIFFUSIVITY CONTRAST AGENTS FOR MEDICAL IMAGING
#14Novel Compositions that Mimic Adipose Tissue in MRI
#15Methods and materials for identifying and treating autoimmune GFAP astrocytopathy
#16QUANTITATIVE MEASUREMENT OF THE PERIVASCULAR SPACE FOR CNS AND BRAIN DISORDERS
#17Tetanus toxoid and CCL3 improve DC vaccines
#18A SERIES OF CATALYSTS FOR THE HYPERPOLARISATION OF SUBSTRATES
#19Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
#20Ascorbate formulations and methods of use as contrast agents
#21Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices
#22Estrogen therapy for brain gray matter atrophy and associated disability
#23MAGNETIC APPARATUS
#24Hybrid multiferroic nanoparticles as MRI contrast agent for sensing of electric fields in a human body
#25Methods for preserving a subject and using imaging contrast agents
#26METHOD FOR INTEGRATING LARGE SCALE BIOLOGICAL DATA WITH IMAGING
#27Nanoparticle, contrast agent for magnetic resonance imaging containing same, and ligand compound
#28MALIGNANT TUMOR TARGET PEPTIDE
#29Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
#30Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
#31Contrast agents for magnetic resonance imaging
#32Multipurpose medical image indicator and method for manufacturing the same
#33Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
#34COMPOSITIONS AND DEVICES TO ADMINISTER PHARMACEUTICAL COMPOSITIONS NASALLY
#35Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices
#36Methods and materials for identifying and treating autoimmune GFAP astrocytopathy
#37SYSTEM AND METHOD FOR IMAGING MACROPHAGE ACTIVITY USING DELTA RELAXATION ENHANCED MAGNETIC RESONANCE IMAGING
#38Determination of structure and traversal of occlusions using magnetic particles
#39Process for the preparation of hyperpolarized carboxylate compounds
#40Pharmaceutical Compositions of Near IR Closed Chain, Sulfo-Cyanine Dyes
#41NON-INVASIVE DETECTION OF DISEASE PROGRESSION AND THERAPEUTIC EFFICACY FOR MUSCULAR DYSTROPHIES AND DISEASES
#42Metal complexes with bisphophonate or pyrophosphate useful as imaging agents
#43NANOPARTICLE DIAGNOSTIC AND METHODS FOR TREATING DISEASE
#44Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
#45Method of purifying metal oxide particles and uses thereof
#46Ascorbate formulations and methods of use as contrast agents
#47Malignant tumor target peptide
#48Manganese complexes with substituted bisphosphonates useful as imaging and therapeutic agents
#49System and Method For Evaluation of Subjects Using Magnetic Resonance Imaging and Oxygen-17
#50Calibration of MRI systems using pre-defined concentrations of F isotopes as reference
#51METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#52Non-nutritive sweeteners and polyols as imaging agents
#53Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices
#54Systems and methods for minimally-invasive assessment of toxicity-induced tissue injury
#55Magnetic apparatus
#56MAGNETIC APPARATUS
#57Imaging phantom and systems and methods of using same
#58Method and image processor for evaluating a contrast agent-enhanced magnetic resonance slice image of a heart
#59METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#60Tetanus toxoid and CCL3 improve DC vaccines
#61HYPERPOLARIZATION OF AMINO ACID RESIDUES FOR PRODUCING HYPERPOLARIZED PEPTIDES
#62Contrast agents for magnetic resonance imaging
#63Quantifying mass effect deformation with structural radiomics in brain tumor patients
#64In vivo detection of a xenon-binding cage molecule
#65CONTRAST AGENTS BASED ON LONG-LIVED NUCLEAR SINGLET STATES AND RELATED METHODS
#66INTRADIALYTIC ADMINISTRATION OF SODIUM THIOSULFATE
#67In vivo detection of EGFR mutation in glioblastoma via MRI signature consistent with deep peritumoral infiltration
#68Estrogen therapy for brain gray matter atrophy and associated disability
#69Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
#70Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
#71Using Heavy Water as a Contrast Agent for Hydrogen Magnetic Resonance Imaging
#72SYSTEMS AND METHODS OF DETECTING INTERSTITIAL CYSTITIS
#73Ascorbate formulations and methods of use as contrast agents
#74Contrast agents for magnetic resonance imaging
#75Pharmaceutical compositions of near IR closed chain, sulfo-cyanine dyes
#76Room temperature ferromagnetic gadolinium silicide nanoparticles
#77COMPOSITION FOR USE IN IMAGING
#78RECEPTOR IMAGING SYSTEMS AND RELATED METHODS
#79Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices
#80METHODS OF TREATMENT OF CANCER
#81Multipurpose medical image indicator and method for manufacturing the same
#82Multicore Magnetic Particles
#83METHODS OF TREATING BRAIN DISORDERS OR IDENTIFYING BIOMARKERS RELATED THERETO
#84Tetanus toxoid and CCL3 improve DC vaccines
#85Method for preparing a pharmaceutical formulation of lanthanide chelate in powder form
#86Imaging brown adipose tissue with curcumin derivatives
#87Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
#88Nanoparticle Diagnostic and Methods for Treating Disease
#89SYSTEMS AND METHODS OF DETECTING INTERSTITIAL CYSTITIS
#90Cobalt-based MRI contrast agent and imaging system
#91Octapod iron oxide nanoparticles as high performance Tcontrast agents for magnetic resonance imaging
#92Alkoxyamines for the treatment of cancers
#93IMAGING OF CREATINE KINASE ENZYME EXPRESSION IN CANCEROUS TISSUES
#94Systems and Methods to Image Intercellular and Intercompartmental Defects with Magnetic Resonance Imaging (MRI)
#95Imaging diagnostics by combining contrast agents
#96Methods for evaluating brain-wide paravascular pathway for waste clearance function and methods for treating neurodegenerative disorders based thereon
#97Methods for the Treatment of Multiple Sclerosis
#98Manganese-based magnetic resonance contrast agents
#99MANGANESE-BASED MAGNETIC RESONANCE CONTRAST AGENTS
#100Pharmaceutical formulations
#101TREATMENT OF NEUROLOGICAL DISORDERS
#102Devices and methods for parahydrogen induced polarization
#103Superparamagnetic nanoparticles as a contrast agent for magnetic resonance imaging (MRI) of magnetic susceptibility (T2*)
#104Nanoparticulate contrast agent
#105IMAGING MARKER AND UTILIZATION THEREOF
#106Exendin-4 Peptide Analogues
#107Compositions and methods for treating or preventing osteoarthritis
#108Using Heavy Water as a Contrast Agent for Hydrogen Magnetic Resonance Imaging
#109Contrast agents based on long-lived nuclear singlet states and related methods
#110Cobalt-based MRI contrast agent and imaging system
#111Method for the Treatment of Multiple Sclerosis
#112Tumorspecific PET/MR(T1), PET/MR(T2) and PET/CT contrast agent
#113Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
#114METHOD OF USING THE NOVEL POLYMER GEL FOR MAGNETIC RESONANCE IMAGING (MRI) VALIDATION
#115CHEMICAL EXCHANGE SATURATION TRANSFER ANGIOGRAPHY
#116Color tunable multifunctional nanophosphor, synthesis method thereof, and polymer composite including the nanophosphor
#117Magnetic resonance imaging (MRI) with self-navigation and self-registration
#118Magnetic resonance imaging (MRI) based quantitative liver perfusion analysis
#119Magnetic resonance imaging (MRI) based quantitative kidney perfusion analysis
#120Quantifying magnetic resonance parameters
#121Magnetic resonance imaging (MRI) with dual agent characterization
#122Magnetic resonance imaging with switched-mode current-source amplifier having gallium nitride field effect transistors for parallel transmission in MRI
#123Fiber optic telemetry for switched-mode current-source amplifier in magnetic resonance imaging (MRI)
#124Method for Detection of Characteristics of Organ Fibrosis
#125Opacity technology
#126Fucoidans as ligands for the diagnosis of degenerative pathologies
#127Compositions and methods for assessing and treating adrenal diseases and disorders
#128Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
#129Systems and methods of performing NMR spectroscopy and MRI
#130Contrast agents
#131Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
#132Treatment of cognitive impairment in a subject with a neurological autoimmune disease
#133Opacity technology
#134Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
#135DEEP BRAIN STIMULATION OF MEMORY CIRCUITS IN ALZHEIMER'S DISEASE
#136Method and apparatus for noninvasive quantitative detection of fibrosis in normal and viable myocardium by MRI
#137Biodegradable Magnetic Nanoparticles and Related Methods
#138USE OF GELSOLIN TO TREAT MULTIPLE SCLEROSIS AND TO DIAGNOSE NEUROLOGIC DISEASES
#139Therapeutic angiogenesis for treatment of the spine and other tissues
#140Imaging diagnostics by combining contrast agents
#141Nanoparticles based on gadolinium coordination polymers as highly sensitive T1 MRI contrast agents
#142Using Heavy Water as a Contrast Agent for Hydrogen Magnetic Resonance Imaging
#143SINGLE VIAL FORMULATION FOR MEDICAL GRADE CYANOACRYLATE
#144Method and system for quantitative renal assessment
#145Formation and uses of europium complexes
#146Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
#147METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#148METHOD FOR INTEGRATING LARGE SCALE BIOLOGICAL DATA WITH IMAGING
#149MRI markers, delivery and extraction systems, and methods of manufacture and use thereof
#150Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies
#151Methods and compositions for improved F labeling of proteins, peptides and other molecules
#152Systems and methods for measuring and modeling in vivo manganese ion transport in a subject
#153Treatment of neurological disorders
#154PROTEIN-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF COLORECTAL ADENOCARCINOMA
#155Method for the Generation of Nuclear Hyper-Antipolarization in Solids Without the Use of High Magnetic Fields or Magnetic Resonant Excitation
#156Method for preparing a pharmaceutical formulation of lanthanide chelate in powder form
#157Method for estimating the physiological parameters defining the edema induced upon infusion of fluid from an intraparenchymally placed catheter
#158Opacity technology
#159Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
#160DIAGNOSTIC AND/OR THERAPEUTIC AGENT, METHOD FOR THE MANUFACTURE THEREOF AND USE THEREOF
#161IMAGING DIAGNOSTICS BY COMBINING CONTRAST AGENTS
#162Contrast Agents For Detecting Protease Activity By Means Of Hyperpolarization And For Stratifying Patients
#163EVALUATING CENTRAL NERVOUS SYSTEM
#164METHOD FOR INTEGRATING LARGE SCALE BIOLOGICAL DATA WITH IMAGING
#165METHODS FOR IN VIVO EVALUATION OF PULMONARY PHYSIOLOGY AND/OR FUNCTION USING NMR SIGNALS OF POLARIZED 129XE
#166SYSTEM FOR FLUORINATING ORGANIC COMPOUNDS
#167AGENT FOR TRANSPORTING NUCLEAR SPIN ORDER AND FOR MAGNETIC RESONANCE IMAGING
#168Contrast agents
#169Use of the spin crossover complex [m(L)H]AN)as a magnetic resonance imaging contrast agent
#170Method of delivering cell therapy to a target site
#171Hyperpolaritzation of compounds for NMR, in particular by means of PHIP
#172Magnetic resonance method and apparatus for automated analysis of joint inflammation, joint proteoglycan proportion, and joint osteoarthritis
#173CONTRAST AGENTS FOR DETECTING PROSTATE CANCER
#174METHOD AND APPARATUS FOR NONINVASIVE QUANTITATIVE DETECTION OF FIBROSIS IN THE HEART
#175Hyperthermic technologies and therapeutic uses thereof
#176DRUG FOR ANALYSIS OF WATER TRANSPORT FUNCTION OF MEMBRANE PROTEIN IN BIOLOGICAL TISSUE
#177Use of gelsolin to treat multiple sclerosis and to diagnose neurologic disease (stossel)
#178Intradialytic administration of sodium thiosulfate
#179Imaging Agents
#180SYSTEM FOR DETECTING FUNCTION OF INTESTINAL BARRIER AND METHOD FOR USING THE SAME
#181SINGLE VIAL FORMULATION FOR MEDICAL GRADE CYANOACRYLATE
#182Imaging Correlates of Neurogenesis With MRI
#183System and method for indirectly measuring calcium ion efflux
#184MAGNETIC RESONANCE IMAGING CONTRAST AGENTS CONTAINING WATER-SOLUBLE NANOPARTICLES OF MANGANESE OXIDE OR MANGANESE METAL OXIDE
#185Hyperpolarized solid materials with long spin relaxation times for use as imaging agents in magnetic resonance imaging
#186Radicals and their use as paramagnetic agents in a DNP process
#187Elimination of contrast agent concentration dependency in MRI
#188Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist
#189Method of cardiac imaging
#190Method of magnetic resonance imaging of the heart with paramagnetic MN
#191Method to produce hyperpolarised carboxylates
#192METHOD FOR ESTIMATING THE PHYSIOLOGICAL PARAMETERS DEFINING THE EDEMA INDUCED UPON INFUSION OF FLUID FROM AN INTRAPARENCHYMALLY PLACED CATHETER
#193Situ Hyperpolarization of Imaging Agents
#194Method and Device For Representing the Microstructure of the Lungs
#195Method for enhancing contrast produced by MRI
#196Methods of diagnosing and alleviating gadolinium toxicity
#197Substituted Porphyrins
#198Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
#199Manganese-enhanced magnetic resonance imaging of neurons using electrical stimulation
#200Method for the treatment of multiple sclerosis
#201Method for optimizing cancer therapy by monitoring maturation of tumor associated vasculature by selenium
#202METHOD FOR DISPLAY PRESENTATION OF LYMPH NODES
#203Compositions and Methods for the Direct Therapy of Tumors
#204Substituted Porphyrins
#205Method for monitoring protein translation
#206Methods for in vivo evaluation of pulmonary physiology and/or function using NMR signals of polarized Xe
#207Inhibitor imaging agents
#208Method for integrating large scale biological data with imaging
#209Method for monitoring early treatment response
#210Method for monitoring early treatment response
#211Method of magnetic resonance imaging
#212Galenical formulations
#2131,4,7,10-Tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them
#214Substituted porphyrins
#215Dual gradient echo pulse sequence using interleaved spiral-out spiral-in k-space trajectories
#216Magnetic resonance with stimulation
#217MRI method for measuring tumor hemodynamic parameters in the presence of contrast agent extravasation
#218High resolution metabolic brain imaging
#219Agents for imaging and diagnostic methods using them
#220Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist
#221Compositions and methods for determining substrate specificity of hydrolytic enzymes
#222Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
#223Aminocarboxylate ligands having substituted aromatic amide moieties
#224Metal complex compounds
#225Method for determining in vivo concentration of a metabolite
#226Method and apparatus for quantitatively evaluating a kidney
#227Pharmaceutical composition for treating multiple sclerosis
#228Unassisted robotic surgery employing paramagnetic halo metallofullerenes as minimally invasive, precision scalpels or micronization particles through magnetic field manipulation and targeted exenteration patterned by programmed 3D imaging using needle or magnetic energy access and microelectronic semiconducting in non-stationary wafer-less space